Clover Health Investments, Corp. CLOV
Set alert
4.46 USD -0.12 -2.62%
At close · Oct 30
4.46 0.00 0.00%
After hours · Oct 30, 7:57 PM ET
4.35 Day range 4.57
1.70 52-week range 5.41
- YTD
- +89.79%
- 1 year
- +28.53%
- Open
- 4.53
- Prev close
- 4.58
- Mkt cap
- 2.37B
- Vol
- 4.65M
- Avg vol
- 4.19M
- EPS
- -0.05
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 4.35
- High
- 4.57
- Forward P/E
- 29.73
- Beta
- 2.46
- Short ratio
- 5.73
- Inst. own
- 33.92%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Nov 4, 2026
- 50-d avg
- 4.50
- 200-d avg
- 3.53
- 1y target
- 5.50
3M chart
Events in this range
- Aug 5, 2026Earnings: 0.05; estimate 0.03864; surprise 29.4%
- Aug 6, 2026Rating: UBS · Neutral → Neutral
- Oct 28, 2026Rating: Needham · — → Buy
Signals (28)
| Name | Date | Ago |
|---|---|---|
| SMA: Bearish | Oct 30, 2026 | 1 day ago |
| SMA: Bullish | Oct 27, 2026 | 4 days ago |
| SMA: Bearish | Oct 26, 2026 | 5 days ago |
| MACD: Sell Signal | Oct 23, 2026 | 1 week ago |
| SMA: Bullish | Oct 20, 2026 | 1 week ago |
| SMA: Bullish | Oct 20, 2026 | 1 week ago |
| MACD: Buy Signal | Oct 20, 2026 | 1 week ago |
| SMA: Bearish | Oct 19, 2026 | 1 week ago |
| MACD: Sell Signal | Oct 19, 2026 | 1 week ago |
| SMA: Bearish | Oct 16, 2026 | 2 weeks ago |
| MACD: Buy Signal | Oct 6, 2026 | 3 weeks ago |
| SMA: Bullish | Oct 5, 2026 | 3 weeks ago |
| SMA: Bullish | Oct 5, 2026 | 3 weeks ago |
| SMA: Bearish | Sep 28, 2026 | 1 month ago |
| SMA: Bearish | Sep 28, 2026 | 1 month ago |
| MACD: Sell Signal | Sep 25, 2026 | 1 month ago |
| RSI: Overbought | Sep 14, 2026 | 1 month ago |
| SMA: Bullish | Sep 10, 2026 | 1 month ago |
| SMA: Bullish | Sep 9, 2026 | 1 month ago |
| MACD: Buy Signal | Sep 1, 2026 | 2 months ago |
| MACD: Sell Signal | Aug 18, 2026 | 2 months ago |
| SMA: Bearish | Aug 17, 2026 | 2 months ago |
| SMA: Bullish | Aug 14, 2026 | 2 months ago |
| SMA: Bearish | Aug 10, 2026 | 2 months ago |
| SMA: Bearish | Aug 10, 2026 | 2 months ago |
| SMA: Bullish | Aug 7, 2026 | 2 months ago |
| MACD: Buy Signal | Aug 7, 2026 | 2 months ago |
| SMA: Bullish | Aug 6, 2026 | 2 months ago |
Financial health
Altman Z-Score
3.42 Safe zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
3 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
D+1 / 5 overall
- DCF 1
- Return on Equity 1
- Return on Assets 1
- Debt / Equity 1
- P/E 1
- P/B 1
Valuation
P/E -13.8×
FY 2018 5y median -3.0× FY 2025
P/S 0.6×
FY 2018 5y median 0.6× FY 2025
P/B 3.9×
FY 2018 5y median 3.3× FY 2025
P/FCF -17.6×
FY 2018 5y median -3.9× FY 2025
EV/EBITDA -13.6×
FY 2018 5y median -2.6× FY 2025
EV/Sales 0.6×
FY 2018 5y median 0.6× FY 2025
FCF Yield -5.7%
FY 2018 5y median -16.2% FY 2025
Profitability
Gross Margin 18.5%
FY 2018 5y median 18.5% FY 2025
Operating Margin -4.4%
FY 2018 5y median -16.3% FY 2025
Net Margin -4.4%
FY 2018 5y median -16.9% FY 2025
ROE -27.7%
FY 2018 5y median -74.5% FY 2025
ROIC -25.7%
FY 2018 5y median -66.0% FY 2025
ROA -15.8%
FY 2018 5y median -37.4% FY 2025
Growth (YoY)
Revenue 40.3%
FY 2018 FY 2025
Operating Income -87.0%
FY 2018 FY 2025
EPS (diluted) -93.6%
FY 2018 FY 2025
Free Cash Flow -307.2%
FY 2018 FY 2025
Financial Health
Current Ratio 1.5×
FY 2018 5y median 1.6× FY 2025
Quick Ratio 1.5×
FY 2018 5y median 1.6× FY 2025
Debt / Equity 0.0×
FY 2018 5y median 0.0× FY 2025
Net Debt / EBITDA 0.9×
FY 2018 5y median 0.5× FY 2025
Interest Coverage 0.0×
FY 2018 5y median -37.7× FY 2025
Dividends
Dividend Yield 0.0%
FY 2018 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2018 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31